Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

June 2, 2014
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches “RACOL-NF Semi Solid for Enteral Use” on June 2, 2014
May 23, 2014
Otsuka Pharmaceutical

Launch in Japan of Samsca 30 mg Tablet Formulation for Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD), an Orphan Disease
May 23, 2014
Taiho Pharmaceutical

Anticancer Drug Lonsurf® Combination Tablet Receives NHI Reimbursement Price Listing and is Scheduled for Launch
May 20, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Named the Major Official Sponsor of Inter-High School Athletic Championships for Two Consecutive Years Special Website Features Fan-produced Support Movies and First Streaming Broadcast of All Competitions
May 15, 2014
Otsuka Pharmaceutical

Otsuka's POCARI SWEAT Aims the Very First Moon Landing Private Firms Take the Lead in the Start of "LUNAR DREAM CAPSULE PROJECT" Delivering all children's dreams 380,000KM to the moon
May 14, 2014
Otsuka Holdings

Notice Regarding the Partial Amendment of Articles of Incorporation
May 14, 2014
Otsuka Holdings

Otsuka Holdings Announces Personnel Changes of Representative Director, Directors and Audit & Supervisory Board Members
May 14, 2014
Otsuka Holdings

Notice Regarding Differences between Non-Consolidated Actual Results for the Fiscal Year Ended March 31, 2013 and Fiscal Year Ended March 31, 2014
May 12, 2014
Taiho Pharmaceutical

Taiho Oncology's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer
April 30, 2014
Otsuka Holdings

Otsuka announces 2014 first quarter U.S. net sales figures of ABILIFY®
April 30, 2014
Otsuka Pharmaceutical

Otsuka Wins European Marketing Authorization for Deltyba™ (delamanid)
April 22, 2014
Taiho Pharmaceutical

ET-743 (trabectedin), a Novel Antitumor Agent Meets Primary Endpoint of Progression Free Survival Prolongation in a Phase 2 Trial in Malignant Soft Tissue Sarcoma Patients
April 9, 2014
Otsuka Pharmaceutical

New SOYJOY Almond & Chocolate Combines Crunchy Almonds, Subtly Sweet Chocolate and the Goodness of Soy The Perfect Snack for Busy Business People
April 1, 2014
Otsuka Pharmaceutical

POCARI SWEAT ION WATER First Overseas Distribution Launched by King Car Otsuka in Taiwan
April 1, 2014
Otsuka Pharmaceutical

"QuickNavi Strep A" April 14 Market Launch in Japan Test Kit for the Rapid Detection of Group A Beta-hemolytic Streptococcal Antigen
March 31, 2014
Otsuka Pharmaceutical

Otsuka Acquires Rights to Hematological Cancer Treatment Dacogen® From Eisai (U.S.)
March 27, 2014
Otsuka Holdings

Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 For the Treatment of Acid-related Diseases in the Gastrointestinal Therapeutic Area
March 27, 2014
Otsuka Pharmaceutical

Otsuka and Takeda Announce a Co-promotion Agreement in Japan of TAK-438 For the Treatment of Acid-related Diseases in the Gastrointestinal Therapeutic Area
March 26, 2014
Otsuka Pharmaceutical

IBM and Otsuka Develop Transformative Care Coordination Solution
March 24, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical's Samsca® Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
March 24, 2014
Taiho Pharmaceutical

Taiho's Lonsurf® (trifluridine and tipiracil hydrochloride) Tablets Approved in Japan for Treatment in Advanced Metastatic Colorectal Cancer
March 17, 2014
Otsuka Pharmaceutical

On April 7, Otsuka Pharmaceutical Will Launch in Japan the Number-One Diet Food Product in France, "Milical"
March 13, 2014
Otsuka Pharmaceutical

Launch of EQUELLE Equol-containing food derived from soybeans A new option for women's health who are 40 and over during and after menopause
March 7, 2014
Otsuka Pharmaceutical

Anti-Epileptic Drug E Keppra® Filed in Japan for Additional Indication of Monotherapy for Partial-Onset Seizures
March 4, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Opens a Second Day Care Center - the "Beanstalk Kids Center OSAKA" - at Otsuka's New Office Building in Osaka
March 4, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical was Awarded "Diversity Management Selection 100" from the Japan Ministry of Economy, Trade and Industry
March 3, 2014
Otsuka Holdings

INVESTIGATIONAL COMPOUND BREXPIPRAZOLE MET PRIMARY AND SECONDARY STUDY ENDPOINTS IN PHASE III CLINICAL TRIAL IN MAJOR DEPRESSIVE DISORDER (MDD)
February 28, 2014
Otsuka Pharmaceutical

Agreement to Renew Memorandum of Understanding Between Otsuka Pharmaceutical and the Ministry of Health and Welfare of South Korea
February 25, 2014
Otsuka Pharmaceutical

Otsuka's Antipsychotic Aripiprazole Awarded the 60th Okochi Memorial Prize
February 24, 2014
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports the Tokyo Marathon 2014 Runners With Amino Value, the Official Beverage